TLT — Theralase Technologies Share News
0.000.00%
Last trade - 00:00- CA$72.69m
- CA$72.12m
- CA$0.82m
Brief: Theralase Commences $CAN 2.5 M Follow-On Private Placement Equity Financing
Brief: Theralase Closes $2.5 Mln Private Placement Equity Financing
Brief: Theralase Phase IB NMIBC Clinical Study Published
Brief: Theralase® Demonstrates Proof-Of-Concept For Canadian-Made COVID-19 Vaccine
Brief: Theralase Expands Intellectual Property Portfolio
Brief: Theralase Technologies Appoints Arkady Mandel Interim CEO
Brief: Theralase Announces Leadership Transition
Brief: Theralase Launches Seventh Us-Based Clinical Study Site And Treats First Patient In The Us
Brief: Theralase announces proposed public offering of units